Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluoroquinolones and surgical prophylaxis

P Dellamonica1, E Bernard

  • 1Department of Infectious Diseases, Archet Hospital, Nice, France.

Drugs
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Revue neurologique·2026
Same author

The interplay of clonal hematopoiesis and cancer: Clinical implications in oncology.

Cancer treatment reviews·2026
Same author

Microstructure of magnesium silicate hydrate pastes influenced by carbonate and mixing method.

Materials and structures·2025
Same author

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

European journal of neurology·2025
Same author

Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER-positive/HER2-negative breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

<i>Aspergillus</i>, <i>Penicillium</i>, and <i>Talaromyces</i> (<i>Eurotiales</i>) in Brazilian caves, with the description of four new species.

Fungal systematics and evolution·2025
Same journal

The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

Drugs·2026
Same journal

Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

Drugs·2026
Same journal

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Drugs·2026
Same journal

Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

Drugs·2026
Same journal

Relacorilant: First Approval.

Drugs·2026
Same journal

Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

Drugs·2026
See all related articles

Fluoroquinolones show promise in preventing surgical wound infections, often proving as effective as standard treatments. Further research is needed to confirm their role and assess risks like antimicrobial resistance.

Area of Science:

  • Infectious Diseases
  • Surgical Sciences
  • Pharmacology

Background:

  • Surgical site infections (SSIs) are a significant complication, with incidence rates varying by procedure type.
  • Surgical antimicrobial prophylaxis is recommended for certain procedures to reduce SSI rates.
  • Fluoroquinolones are emerging as potential prophylactic agents due to their antimicrobial and pharmacokinetic properties.

Purpose of the Study:

  • To evaluate the efficacy of fluoroquinolones as surgical antimicrobial prophylaxis.
  • To compare fluoroquinolone-based prophylaxis with standard regimens and placebo across various surgical specialties.
  • To assess the optimal dosing strategies for fluoroquinolone prophylaxis.

Main Methods:

  • Systematic review and meta-analysis of randomized clinical trials comparing fluoroquinolones with standard prophylaxis or placebo.

Related Experiment Videos

  • Analysis of clinical trial data from orthopaedic, cardiovascular, biliary, colorectal, and urological surgeries.
  • Evaluation of single-dose versus multiple-dose fluoroquinolone regimens.
  • Main Results:

    • Fluoroquinolones demonstrated comparable efficacy to standard prophylactic agents in most studies.
    • A reduction in postoperative wound infections was observed in patients receiving fluoroquinolones compared to placebo in transurethral surgery.
    • Single-dose fluoroquinolone prophylaxis was generally as effective as multiple-dose regimens.

    Conclusions:

    • Fluoroquinolones are effective in surgical prophylaxis, particularly in transurethral surgery.
    • Methodological limitations in existing trials necessitate further high-quality research.
    • Future studies should focus on cost-benefit analysis, high-risk procedures, and the potential for antimicrobial resistance and adverse effects.